[1]JournalofMedicinalChemistry,2005,vol.48,p.792-804
[1]JournalofMedicinalChemistry,2005,vol.48,p.792-804
[1]JournalofMedicinalChemistry,2005,vol.48,p.792-804
[1]JournalofMedicinalChemistry,2005,vol.48,p.792-804
[1]JournalofMedicinalChemistry,2005,vol.48,p.792-804
Title: Testing of the topoisomerase 1 inhibitor Genz-644282 by the pediatric preclinical testing program.
Journal: Pediatric blood & cancer 20120201
Title: Molecular and cellular pharmacology of the novel noncamptothecin topoisomerase I inhibitor Genz-644282.
Journal: Molecular cancer therapeutics 20110801
Title: Genz-644282, a novel non-camptothecin topoisomerase I inhibitor for cancer treatment.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20110501
Title: 5-(2-aminoethyl)dibenzo[c,h][1,6]naphthyridin-6-ones: variation of n-alkyl substituents modulates sensitivity to efflux transporters associated with multidrug resistance.
Journal: Journal of medicinal chemistry 20050210
Title: Kurtzberg LS, et al. Genz-644282, a novel non-camptothecin topoisomerase I inhibitor for cancer treatment. Clin Cancer Res. 2011 May 1;17(9):2777-87.
Title: Houghton PJ, et al. Testing of the topoisomerase 1 inhibitor Genz-644282 by the pediatric preclinical testing program. Pediatr Blood Cancer. 2012 Feb;58(2):200-9.
Title: Sooryakumar D, et al. Molecular and cellular pharmacology of the novel noncamptothecin topoisomerase I inhibitor Genz-644282. Mol Cancer Ther. 2011 Aug;10(8):1490-9.
